2024

(Summary description)2024

2024

(Summary description)2024

Information
KX-826 Received The INCI Designation
KX-826 Tincture 1.0% Clinical Trial For The Treatment Of Male Adult AGA In China Received Clearance By NMPA
GT20029 Phase II Clinical Trial for Treatment of AGA in China Reached Primary Endpoint
KX-826 Phase Ib/III Clinical Trial of Combination Therapy with Minoxidil For The Treatment of Male AGA Received Clearance by China NMPA

Scan the QR code to read on your phone